← All sarcoma trials
Recruiting nowPhase 2Ages 18 Years to 100 Years

Fluorescent Intra-operative Tumor Margin Examination

Sponsor: Kurt Weiss · NCT04719156 on ClinicalTrials.gov ↗

Conditions studied

Sarcoma

What it tests

  • Indocyanine green solution administered at 2.0mg/kg.drug
  • Stryker SPY-PHI Imaging Devicedevice

Where it's running1 site

  • UPMC-Shadyside Hospital

    Pittsburgh, Pennsylvania 15213

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Patients above the age of 18 with a primary musculoskeletal tumor that has been indicated for surgical excision by a fellowship trained orthopaedic oncologist.
* Surgical consent was obtained prior to research consent.
* Patients with a biopsy-confirmed primary soft tissue or bone tumor that has not been previously excised and has a known risk of local or remote recurrence.

Exclusion Criteria:

* Patients below the age of 18
* Pregnancy, breast feeding
* Patients with a history of anaphylactic reaction to contrast media or fluorescein allergy
* Prior surgery local to the mass being excised
* Non- or minimally-recurrent masses (i.e. osteochondroma)
* Dialysis, renal failure, uremia

Updated 2026-02-20 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.